13 signs the Big Bank Conspiracy is a moral threat

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
13 signs the Big Bank Conspiracy is a moral threat

Commentary: Goldman’s ‘soul sick’ pathology is spreading


By Paul B. Farrell, MarketWatch
Aug. 12, 2013, 10:00 a.m. EDT

SAN LUIS OBISPO, Calif. (MarketWatch) — The symptoms of a deadly Big Bank moral pathology are everywhere. But they can’t see. And it’s getting worse. Does America see?

Do you? Yes, Big Banks are morally blind, do not care what taxpayers, investors and politicians think ... Huffington Post says eight agencies are investigating J.P. Morgan for fraud, while CEO Jamie Dimon yawns ... billionaires are saving three times what they did in 2007, they see the crash coming ... Bill Gross says the 30-year bull in our $32 trillion bond market is over, “you’re going to lose money investing” ... Economist Robert Gordon warns that America’s GDP growth will be less than 1% by 2100.

But Big Banks have short-term brains. They only see the one rule of capitalism: Make profits. What about public interest? Not part of a corporation agenda. Not with CEOs like Dimon and Goldman Sachs’s Lloyd Blankfein, traders, executives and vice presidents who expect huge bonuses. Short-term profits always trump long-term public interests. Always.


Pedestrians walk past Goldman Sachs Group Inc. headquarters in New York

Has Goldman’s moral pathology infected a Big Banks Conspiracy?

Let me remind you again of John C. Bogle’s great classic, “The Battle for the Soul of Capitalism: How the Financial System Undermined Social Ideals, Damaged Trust in the Markets, Robbed Investors of Trillions.” That was 2005, Vanguard’s founder warned us Adam Smith’s “invisible hand” was no longer driving “capitalism in a healthy, positive direction.”

Bogle saw a “happy conspiracy” of Wall Street, Washington and Corporate America was spreading a “pathological mutation of capitalism” driven by the new “invisible hands” of this conspiracy pushing their selfish agenda in a war to control American democracy and capitalism. Goldman Sachs had a winning hand, and the competition wanted one too.

They won: Democracy is dead. Capitalism is dead. Our moral compass is broken. More proof? See for yourself the 13 signs of the “pathological mutation of capitalism” that Bogle fears. How it’s metasticized right under our noses. How Goldman’s pathogens spread so rapidly since the 2008 crash they are infecting every other Wall Street bank, plus the global Big Banks Conspiracy, the world’s top hundred banks?

You decide. See for yourself: Here are earlier news reports paraphrasing the 13 symptoms of a “soul sickness” pandemic spreading from Goldman Sachs’s pathology:

1. Messiah complex

London Times’ John Arlidge interviewed Goldman CEO Blankfein: In 2007 he paid himself $68 million ... now worth more than $500 million, yet insists banking has a social purpose ... he’s a “blue-collar guy” ... just doing “God’s work.” When I was at Morgan Stanley we ran an ad: “If God Wanted To Do a Financing, He Would Call Morgan Stanley.” And kill America?

2. Conflicts of interests

New York Times: ‘Before becoming Treasury Secretary in 2006, Hank Paulson agreed to hold himself to a higher ethical standard than his predecessors. He specifically said he’d avoid his old buddies at Goldman where he was CEO. Later Congress saw many conflicts of interest, not just meetings but favorable treatment for his buddies at Goldman.’

3. Arrogant vampires


Four years ago in Seeking Alpha: “Goldman is America’s most hated corporation.” Rolling Stone’s Matt Taibbi called Goldman “a giant vampire squid wrapped around the face of humanity.” Bank greed triggered the crash. Investors suffered heavy losses. But banks got bailouts, enjoyed $30 billion in bonuses.’ Banks are convinced: What’s good for Goldman is good for the country. What’s good for Goldman is good for the world.

4. Paranoid secrecy

Bloomberg exposed the “NY Fed’s Secret Deal on AIG” ... paid off $180 billion in AIG swaps backing CDOs ... Paulson and Bernanke bailed out Goldman for $13 billion more taxpayer money than necessary, saving them from bankruptcy, fleecing the public.

5. Perjurers on top

Wall Street Journal: Goldman insisted no damage if AIG collapsed. A later report killed that excuse. Even then New York Fed Chairman Timothy Geithner admitted Goldman was legally obligated to cover AIG losses. They lied: if AIG collapsed, Goldman would be bankrupt.

6. Pathological liars

McClatchy News: “Goldman secretly bet on the U.S. housing crash after peddling more than $40 billion in securities backed by 200,000 risky home mortgages ... but never told investors they were secretly betting on a drop in housing prices that could wipe out the value of the securities.” Treasury Secretary Paulson knew, but never disclosed: “Goldman’s triple-A investments were junk.”

7. Ratings con game

New York Examiner: “Goldman was at the heart of the subprime crash, selling subprime junk as no-risk AAA bonds, then gambling, hedging, shorting these investments ... That set up the meltdown. ... taxpayers got stuck with the bill.” McClatchy exposed how Moody’s made billions selling triple-A ratings; a U.S. bailout overseer “called this reckless gambling.”

8. Greedy foreclosers

McClatchy News reported that “an obscure Goldman subsidiary spent years buying hundreds of thousands of subprime mortgages ... repackaged them ... The bottom fell out. Now, after years of refusing to disclose they owned the mortgages, the secret is out” — Goldman is “one of America’s biggest, greediest foreclosers.”

9. Phony confessions

CBS MoneyWatch: “Blankfein now says he’s ‘sorry for the role Goldman played in the housing crisis: We participated in things that were clearly wrong.’ Wrong? Isn’t that an outright admission of something ‘clearly criminal.’ He admits to a criminal fraud, offers some phony ‘restitution,’ $100 million annually for 5 years to small business owners. That’s Goldman’s profits from one good trading day. Yet, no prosecutions.”

10. Cheating government

Barron’s: Geithner bragged about the fabulous returns taxpayers made off the Goldman deal: 23% return on $5 billion. Meanwhile, Buffett’s loan guarantee to Goldman netted him a 120% return as Goldman’s shares went from $115 to $180, plus 8% warrants.

11. Charity is PR stunt

New York Times examined Goldman charitable foundation’s tax filing: “The money to Goldman’s foundation is dwarfed compared to insiders’ bonuses. The foundation got $400 million, gave away $22 million. Bonuses were 20 times more.” Good PR?

12. Shorting Christmas

USA Today wrote Goldman should be celebrating the holidays. But the mood at the bank was one of crisis about the public backlash over huge employee bonuses. So they canceled the party, went on a PR blitz to cover up the damage, launching a $500 million program for small businesses. Bottom line, for Big Banks all moral issues are simply PR problems.

13. Blind money addicts

New York Times’ Maureen Dowd: “Goldman’s trickle-down catechism isn’t working. We have two economies. In the past decade Wall Street’s shared little with society. Their culture is totally money-obsessed. There’s always room for a bigger house, bigger boat. If not, you’re falling behind. It’s an addiction. And Washington’s done little to quell it, coddles wanton bankers. Obama’s absent. ‘Saturday Night Live’ was tougher. And as far as doing God’s work: The bankers who took taxpayer money, pocketing obscene bonuses: They’re the same greedy types Jesus threw out of the temple.’

Now it’s your turn. How bad is it out there? How many of Goldman’s 13 symptoms still fit? Is it worse? How much more has Goldman’s toxic virus metastasized since the 2008 crash? Infected the global Big Banks Conspiracy that’s killing democracy and destroying the economy with its “mutant capitalism?”

Can we do anything about it? Or do we need a total system failure, another Great Depression before the global Big Banks Conspiracy wakes up?

http://www.marketwatch.com/Story/story/print?...2128040CF6

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading